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The kinase-phosphatase pair Csk and CD45 recipro-
cally regulate phosphorylation of the inhibitory tyro-
sine of the Src family kinases Lck and Fyn. T cell
receptor (TCR) signaling and thymic development
require CD45 expression but proceed constitutively
in the absence of Csk. Here, we show that relative
titration of CD45 and Csk expression reveals distinct
regulation of basal and inducible TCR signaling
during thymic development. Low CD45 expression
is sufficient to rescue inducible TCR signaling and
positive selection, whereas high expression is
required to reconstitute basal TCR signaling and
beta selection. CD45 has a dual positive and negative
regulatory role during inducible but not basal TCR
signaling. By contrast, Csk titration regulates basal
but not inducible signaling. High physiologic expres-
sion of CD45 is thus required for two reasons—to
downmodulate inducible TCR signaling during posi-
tive selection and to counteract Csk during basal
TCR signaling.
INTRODUCTION
The T cell receptor (TCR) and its signal transduction machinery
are required during thymic selection in order to establish a func-
tional and tolerant T cell repertoire (Starr et al., 2003). Antigen
peptide bound to major histocompatibility molecules (pMHCs)
triggers inducible TCR signaling by coligating the TCR ab chains
and the CD4 or CD8 coreceptors (Veillette et al., 1989a; Veillette
et al., 1989b). The coreceptor-associated Src-family kinase
(SFK) Lck then phosphorylates the immunoreceptor tyrosine-
activating motifs (ITAMs) of TCR-associated CD3 and z chains
(Kane et al., 2000; Veillette et al., 2002), triggering further down-
stream signaling events.342 Immunity 32, 342–354, March 26, 2010 ª2010 Elsevier Inc.Although such inducible signal transduction has been exten-
sively studied, ‘‘basal’’ signals that occur during thymic develop-
ment also depend upon TCR signaling machinery but are less
well defined. For example, constitutive phosphorylation of the
TCR z chain occurs in double positive (DP; CD4+CD8+) thymo-
cytes and is critical for active downregulation of surface TCR
expression (Myers et al., 2005; Nakayama et al., 1989). Although
Lck, TCRa, and MHCs are all required to mediate z phosphory-
lation, nonselecting MHC backgrounds are sufficient to do so
(van Oers et al., 1994, 1996a; Becker et al., 2007; Sosinowski
et al., 2001). Such nonselecting signals through the TCR are
distinct from those that drive positive selection. We use the
term ‘‘basal’’ here to refer to nonselecting TCR signals, and
‘‘inducible’’ to refer to selecting TCR signals.
Lck activity is tightly regulated by its location as well as by
changes in conformation and enzyme activity that are controlled
by phosphorylation of its inhibitory and activation loop tyrosines,
respectively (Palacios and Weiss, 2004). Reciprocal regulation of
the inhibitory tyrosine of Lck is imposed by the kinase-phospha-
tasepairCskandCD45, therebysettinga thresholdonTCRsignals
(Chow et al., 1993; Hermiston et al., 2009; Veillette et al., 2002).
Csk is a ubiquitously expressed kinase whose only substrate is
the inhibitory tyrosine of the SFKs (Veillette et al., 2002). Condi-
tional deletion of Csk in T cells produces thymocytes that auton-
omously progress through beta selection and positive selection
checkpoints in the absence of TCR expression (Imamoto and
Soriano, 1993; Nada et al., 1993; Schmedt et al., 1998; Schmedt
and Tarakhovsky, 2001). This phenotype is entirely dependent
upon Lck and Fyn, confirming that the function of Csk in
T cells is to negatively regulate these SFKs (Schmedt and Tara-
khovsky, 2001).
CD45 is a receptor-like tyrosine phosphatase abundantly
expressed on all nucleated hematopoietic cells and is required
for both TCR signaling and T cell development (Byth et al.,
1996; Kishihara et al., 1993; Mee et al., 1999; Stone et al.,
1997). CD45 deficient (Ptprc/) mice are characterized by
a partial block at the preTCR beta-selection checkpoint and
a near-complete block at positive selection. Lck inhibitory
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Ptprc/ thymocytes, whereas an Lck Y505F transgene rescues
both TCR signaling and T cell development in these animals, es-
tablishing this tyrosine as a physiologically relevant substrate
and Lck as a critical mediator of CD45 function (Pingel et al.,
1999; Seavitt et al., 1999; Stone et al., 1997). In addition, the
loss of constitutive z phosphorylation in Ptprc/ DP thymocytes
and the impaired beta-selection phenotype of Ptprc/ mice
together suggest a requirement for CD45 in basal TCR signaling
as well (Byth et al., 1996; Stone et al., 1997).
In addition to its positive regulatory role, CD45 has also been
shown to downregulate TCR signaling. Ptprc+/ animals in the
context of a restricted TCR repertoire exhibit enhanced positive
selection (Wallace et al., 1997). Several groups have generated
a series of CD45 single isoform transgenic mice with subphysio-
logic CD45 expression (Kozieradzki et al., 1997; McNeill et al.,
2007; Ogilvy et al., 2003). Hyperresponsive TCR signaling rela-
tive to wild-type was observed at intermediate CD45 expression
(McNeill et al., 2007). It has been suggested that dephosphoryla-
tion of the activation loop tyrosine of the SFKs might mediate
the negative regulatory role of CD45 (Ashwell and D’Oro, 1999;
McNeill et al., 2007). However, it remains unclear whether these
phenotypes relate purely to CD45 expression level or might be
confounded by the influence of abnormal isoform expression
(McNeill et al., 2007; Salmond et al., 2008).
Here, we have described a coding point mutation in CD45,
lightning, which was identified during a mutagenesis screen. The
lightning mutation reduces surface expression of CD45 without
perturbing alternative splicing, thereby uncoupling expression
and isoform effects. We identified differential requirements for
CD45 during basal and inducible TCR signaling and demon-
strated distinct regulation of these processes by Csk. We
conclude that high physiologic expression of CD45 in the thymus
serves two independent functions. First, high expression of
CD45 is required to counteract phosphorylation of the inhibitory
tyrosine of Lck by Csk in order to promote basal signaling.
Second, although low expression of CD45 is sufficient to rescue
inducible TCR signaling in DP thymocytes, high expression of
CD45 dampens inducible TCR signaling in DP thymocytes by de-
phosphorylating the activation loop tyrosine of Lck, thereby ex-
panding the dynamic range of TCR-ligand interactions at a crit-
ical tolerance checkpoint.
RESULTS
A CD45 Allele, lightning, Produces Low Protein
Expression but Normal Splicing
Flow cytometric screening of peripheral blood from ENU
(N-ethyl-N-nitrosourea)-mutagenized C57BL/6 mice (Nelms
and Goodnow, 2001) identified a mutant strain, lightning, char-
acterized by low surface expression (15% wild-type) of CD45
on all nucleated hematopoietic lineages. (Figures 1A and 1B
and data not shown). Analysis of CD45 expression in lethally irra-
diated hosts reconstituted with lightning bone marrow identified
this trait as hematopoietic and cell intrinsic (data not shown).
Intracellular staining of permeabilized lightning thymocytes
revealed that the total cellular pool of CD45 was also substan-
tially reduced relative to wild-type thymocytes, suggesting that
the expression phenotype is not attributable to a defect in proteintransport (Figure 1C). Importantly, tightly regulated isoform
splicing of CD45, which occurs in a cell-type and develop-
mental-stage-specific program (McNeill et al., 2004), was unper-
turbed in lightning mice (Figure S1A available online).
The lightning phenotype cosegregated with markers flanking
the Ptprc gene encoding CD45 on chromosome 1 (data not
shown). In contrast to CD45 protein expression, Ptprc transcript
expression in lightning thymocytes revealed no reduction relative
to the wild-type (Figure 1D), arguing that the lightning mutation
must lie within the Ptprc transcript rather than in the regulatory
region of the Ptprc gene. Ptprc cDNAs from heterozygous and
homozygous lightning (L/+ and L/L) thymocytes were
sequenced. A nonsynonymous T-C point mutation in the coding
region was identified. This mutation results in a Phe-Ser substitu-
tion in an evolutionarily conserved packing residue F503 (CQFYV)
of the most membrane-proximal extracellular fibronectin type-III
repeat of CD45 (Figure 1E and Figures S1B and S1C).
To determine why the lightning polymorphism produced low
CD45 expression, we treated L/L and wild-type thymocytes with
cycloheximide to inhibit new protein synthesis and assessed
total CD45 protein expression over time. The lightning allele
conferred reduced CD45 protein half-life, presumably because
of impaired protein stability and increased turnover (Figure 1F).
We took advantage of the lightning phenotype to generate an
allelic series of mice with varied CD45 expression by breeding
the lightning strain to null and wild-type Ptprc lines (Figures 1A
and 1B). In subsequent studies, it was determined that the
phenotypes of L/+ and Ptprc+/mice were virtually indistinguish-
able and data from these two genotypes were combined in
several figures.
CD45 Plays a Dual Positive and Negative Regulatory
Role during Positive Selection
We studied the effect of varied expression of CD45 upon positive
selection. Consistent with prior reports, Ptprc/ thymocytes
exhibited a severe block in the transition from DP to single posi-
tive (SP) thymic stages, corresponding to impaired positive
selection. Very low expression of CD45 (L/ = 7% of wild-type)
was sufficient to rescue positive selection and reconstitute SP
thymic subsets in the allelic series (Figure 2A).
Upregulation of surface CD69, CD5, and TCRb expression
identifies DP thymocytes that have received an inducible or posi-
tive selection signal through the TCR (Swat et al., 1993; Azzam
et al., 1998; Punt et al., 1996). Conversely, CD5lo CD69lo TCRbint
expression identifies preselection DP thymocytes that have
not received a strong selecting signal and experience pre-
dominantly basal or nonselecting TCR signaling (Figures S2A–
S2C). Ptprc/ thymocytes exhibited a specific and complete
developmental block at this checkpoint and failed to upregulate
these markers (Mee et al., 1999; Figure 2B and Figure S2B).
Not only was this positive selection checkpoint rescued by low
CD45 expression, but enhanced selection was also seen in
L/ and L/L thymi (Figures 2B–2D). Competitive repopulation
experiments confirmed that this reflects a cell-intrinsic advan-
tage (Figure 2E). Higher levels of CD45 resulted in fewer posi-
tively selected thymocytes. These results suggest that in addi-
tion to its obligate positive regulatory role at this checkpoint,
high CD45 expression inhibits positive selection, unmasking
a negative regulatory role.Immunity 32, 342–354, March 26, 2010 ª2010 Elsevier Inc. 343
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Figure 1. A Single Phe to Ser Substitution in
an Extracellular Fibronectin Repeat of the
CD45 lightning Allele Reduces Protein Half-
Life
(A and B) DP thymocytes from an allelic series of
mice generated by crossing wild-type, lightning,
and Ptprc null alleles were stained for surface
CD45 and assessed by flow cytometry. Represen-
tative histograms as well as CD45 MFI (mean fluo-
rescence intensity) are plotted (genotypes in all
figures: / = Ptprc/; WT = Ptprc+/+; L = Light-
ning allele).
(C) DP thymocytes from allelic series were permea-
bilized, stained for CD45, and assessed by flow
cytometry. Representative histograms are plotted.
(D) Quantitative real-time PCR of Ptprc cDNA from
two L/L and one wild-type thymi are normalized to
GAPDH. Transcript amounts are expressed in
relative units (wild-type CD45 = 1). Data are the
average of three technical replicates.
(E) Sequencing of PCR-amplified Ptprc cDNA frag-
ments from L/L and L/+ thymi. Sequence flanking
mutated residue F503 is shown.
(F) Allelic series thymocytes incubated with CHX
for varying time points. Flow cytometric assess-
ment of permeabilized, stained cells for total
CD45 protein content plotted with respect to
baseline levels is shown. Results are representa-
tive of three independent experiments.
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generation of postselection DP thymocytes, SP4 thymocyte
number as well as thymic cellularity and total DP number was
reduced (Figures 2F–2H; data not shown). Reduction in SP4
production was not due to redirection into the SP8 lineage (data
not shown). Rather, the reduction in cell number between the
DP postselection and the SP4 stages of thymic development
suggests deletion due to enhanced negative selection in L/L and
L/ thymi (Figures 2D and 2H). Indeed, reduced DP cell number
is a hallmark of enhanced negative selection in mouse models
characterized by exaggerated TCR signaling (Gomez et al.,
2001; Thien et al., 2005). To assess this possibility, we stimulated
L/L and wild-type DP thymocytes ex vivo and evaluated upregula-
tion of the negative selection marker Nur77 (Calnan et al., 1995).
Nur77 upregulation was enhanced in L/L DP thymocytes relative
to wild-type thymocytes, suggesting that, similar to positive selec-
tion, negative selection is enhanced by low CD45 expression
(Figure S2D). Reduced DP cell number with low CD45 expression
may therefore be attributed to both enhanced positive and
negative selection. It remains possible that impaired beta selec-
tion or preselection DP survival also influence this phenotype.
Low CD45 Expression Transforms Positive
into Negative Selection
In order to study the functional consequences of CD45 expres-
sion upon positive and negative selection directly, we assessed344 Immunity 32, 342–354, March 26, 2010 ª2010 Elsevier Inc.thymic development in the context of a fixed TCR repertoire by
breeding the allelic series onto the class II-restricted OTII TCR
transgenic line. Consistent with prior reports, Ptprc/ mice
exhibited severely impaired positive selection in the context of
the OTII transgenic background with nearly absent SP4 T cell
production (Figures S2E and S2F; Mee et al., 1999). Unexpect-
edly, the development of SP4 thymocytes was significantly
reduced in OTII allelic series mice expressing low CD45 (Figures
S2E and S2F). Production of mature peripheral CD4+ lymph node
T cells was also impaired in OTII mice expressing low CD45,
although less so than in the thymus (Figure S2G). These OTII
L/L and L/ T cells displayed alternate Va and Vb usage, sug-
gesting strong selection pressure in the thymus (Figure S2H).
Loss of OTII+ SP4 thymocytes in L/L and L/mice may reflect
either failed positive or enhanced negative selection. To distin-
guish between these possibilities, we assessed thymic cellularity
of OTII allelic series thymi and compared it to that of Ptprc/
OTII thymi (Figures S2I and S2J). If reduced SP4 output from
L/ and L/L thymi were due to impaired positive selection,
thymic cell number ought to be high as in Ptprc/ OTII mice.
However, thymic cellularity in L/ and L/L OTII thymi was signif-
icantly reduced by more than 50% relative to Ptprc/ thymi.
This was true of littermate controls and irrespective of age (range
4–9 weeks, Figure S2K). These data suggest that in contrast to
Ptprc/ OTII mice, impaired SP4 output in L/ and L/L OT2
thymi reflects increased negative selection rather than failed
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Figure 2. Dual Positive and Negative Regulatory Roles for CD45 during Positive Selection
(A) Representative plots of allelic series thymocytes costained for CD4 and CD8 for identification of DN, DP, and SP subsets.
(B) Representative plots of allelic series DP thymocytes costained for TCRb and CD5. Gating to identify postselection thymocytes (TCRbhi CD5hi) is based upon
the developmental block in Ptprc/ thymocytes.
(C and D) Quantification of relative and absolute number of TCRbhi CD5hi postselection DP thymocytes as gated in (B). Values are the mean of ten biological
replicates ± SEM.
(E) Competitive chimeras were generated with a 1:1 mix of L/L and WT donor bone marrow. Thymi were stained for pre- and postselection DP thymocytes with
CD4, CD8, TCRb, and CD5, as well as 45.1 and 45.2 allotype markers. Bar graphs represent a ratio of postselection/preselection DP subsets. Data are normalized
to a 1:1 input ratio at the preselection DP subset. Values in the graphs are the mean of five biological replicates ± SEM.
(F) Quantification of SP4/DP ratios from allelic series thymi as stained and gated in (A).
(G) Quantification of absolute DP cell counts from allelic series thymi as stained and gated in (A).
(H) Quantification of absolute SP4 cell counts from allelic series thymi as stained and gated in (A). Values in (F)–(H) are the mean of ten biological repli-
cates ± SEM. In this figure, ‘‘HET’’ refers to both L/+ and Ptprc+/ genotype. Statistical analysis with unpaired t tests was performed; *p < 0.05; **p < 0.005;
***p < 0.0005.
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can transform positive into negative selection in the context of
a restricted TCR repertoire.
High CD45 Expression Is Required to Rescue Basal TCR
Signaling
Beta selection, in contrast to positive selection, is a ligand-inde-
pendent or basal signaling event. This checkpoint requires
pre-TCR signaling and is completely dependent upon Lck and
Fyn (Irving et al., 1998; van Oers et al., 1996b).
Progression from DN3 (double negative) to DN4 stages at the
beta-selection checkpoint was assessed along the allelic series(Figure 3A and Figure S2A). Identity of the cells in the putative
DN4 gate was confirmed with intracellular staining for TCRb
(Figure S3). Ptprc/ thymi, as previously reported, exhibited
a partial block at this critical transition (Figures 3A and 3B).
In contrast to the positive selection checkpoint, high expression
of CD45 was required to fully correct this partial block in beta
selection (Figures 3A and 3B). Competitive repopulation experi-
ments unmasked a partial block in beta selection in L/L thymo-
cytes and demonstrate that this phenotype is cell intrinsic
(Figure 3C). Distinct regulation of beta selection and positive
selection checkpoints by CD45 suggests that basal and ligand-
dependent TCR signals are wired differently. This in turnImmunity 32, 342–354, March 26, 2010 ª2010 Elsevier Inc. 345
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Figure 3. High CD45 Expression Is Required to Rescue Beta Selection and Basal Signaling during Thymic Development
(A) Representative plots of allelic series DN thymocytes (dump staining for CD4, CD8, CD3, CD19, gd, NK1.1, pNK, CD11b, and CD11c; Gr1 was performed to
remove contaminating cell lineages from the gate) stained with CD44 and CD25 to identify subsets DN 1-4 (clockwise from top left). DN3 gate is CD44CD25+ and
DN4 gate is CD44CD25.
(B) Quantification of DN4/DN3 ratios from allelic series thymi as stained and gated in (A). Values are the mean of six biological replicates ± SEM, normalized to
wild-type.
(C) Competitive chimeras were generated with a 1:1 mix of L/L and WT donor bone marrow. Thymi were stained for DN3 and DN4 subsets with the method out-
lined in Figure 3A, as well as with 45.1 and 45.2 allotype markers. Bar graphs represent ratio of DN4/DN3 subsets. Data are normalized to a 1:1 input ratio at the
DN3 subset. Values in the graphs are the mean of three biological replicates ± SEM.
(D) Representative histograms of surface marker expression on unstimulated DP thymocytes from the allelic series. Experimental samples from the allelic series
(black histogram) are each overlayed upon wild-type (gray shaded histogram) for comparison.
(E and F) Quantification of MFI of CD5 and TCRb surface levels respectively from pre-selection DP thymocytes as gated in Figure S2. Values are the mean of six
biological replicates ± SEM, normalized to wild-type.
(G) TCR-associated z chain was immunoprecipitated from whole-cell lysates of resting allelic series thymi. Immunoprecipitates (IPs) were subsequently blotted
for total z and total phosphotyrosine levels. p21 z is depicted. Blots are representative of three independent experiments. In this figure, ‘‘HET’’ refers to both L/+
and Ptprc+/ genotype. Statistical analysis with unpaired t tests was performed; *p < 0.05; **p < 0.005; ***p < 0.0005.
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Roles of CD45 and Csk during Thymic Developmentsuggests that nonselecting (‘‘basal’’) signals during DP thymo-
cyte development may also be distinctly regulated by CD45.
To clarify the role of CD45 during such basal signaling, surface
markers on preselection DP thymocytes within the allelic series
were characterized. CD5 is an inhibitory coreceptor that nega-346 Immunity 32, 342–354, March 26, 2010 ª2010 Elsevier Inc.tively regulates TCR signaling and serves as a well-defined
marker of TCR signal intensity in thymocytes (Azzam et al.,
1998). CD5 expression on preselection DP thymocytes depends
upon Lck, z chain, and nonselecting MHC expression (Azzam
et al., 1998; Dutz et al., 1995). Preselection DP thymocytes
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Figure 4. Differential Influence of CD45 Ex-
pression on Inducible TCR Signaling in DP
and SP Thymocytes
(A) TCR-stimulated, fixed, and permeabilized
thymocytes were stained for phospho-Erk and
costained for CD4 and CD8 so that DP and SP
subsets could be identified. Data were collected
by flow cytometry. Histograms depict intracellular
phospho-Erk in DP and SP subsets from wild-type
(gray shaded histogram) and L/L (black line) thymi.
Data are representative of at least eight indepen-
dent experiments.
(B) Intracellular calcium was assessed by flow cy-
tometry over time in Fluo-4-loaded thymocytes
after TCR or ionomycin stimulation. DP thymo-
cytes were gated by size.
(C) Allelic series thymocytes were stimulated and
stained for intracellular phospho-Erk, CD4, and
CD8 as described in (A). Quantification of cells
which fall into the positive half of a bimodal phos-
pho-Erk distribution (as depicted in [A]). PMA stim-
ulation produced identical upregulation of Erk
phosphorylation in all genotypes (data not shown).
Values are the mean of three independent experi-
ments ± SEM.
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Roles of CD45 and Csk during Thymic Developmentfrom Ptprc/ mice exhibited low CD5 expression, whereas high
CD45 expression was required to reconstitute normal CD5
expression (Figures 3D and 3E). Whereas positive selection is
enhanced by low expression of CD45, basal signaling is
impaired.
TCR surface expression is actively downregulated on wild-
type DP thymocytes. This is due in part to a posttranslational
mechanism that requires a basal TCR signal to produce consti-
tutive phosphorylation of TCR-associated z-chain (Myers et al.,
2005; Nakayama et al., 1989). This signal has been shown to
depend upon nonselecting MHC and Lck expression (Becker
et al., 2007; van Oers et al., 1996a). In the absence of these
factors, TCR expression is constitutively high in DP thymocytes.
We observed that the TCR was not effectively downregulated
upon thymocytes with low CD45 expression (Figures 3D and
3F). Consistent with this observation, basal z phosphorylation
was very low in L/ and L/L animals and inversely correlated
with surface TCR expression (Figure 3G and data not shown).
High expression of CD45 is required to phosphorylate z,
downregulate the TCR, and upregulate CD5 constitutively
upon preselection DP thymocytes. CD45 does not appear to
have a substantial negative regulatory role during basal sig-
naling. In contrast, low CD45 is sufficient not only to rescue
but also to enhance inducible TCR signaling during positive
selection. Hence, a negative role for CD45 is evident in inducible
but not basal signaling in DP thymocytes.
Distinct Effects of CD45 upon Inducible TCR Signaling
in DP and SP Thymocytes
In order to directly determine the effect of CD45 expression upon
TCR signal strength in the thymus, we assayed biochemical
responses to TCR stimulation such as Erk phosphorylationand calcium flux. L/L DP thymocytes displayed enhanced Erk
phosphorylation relative to the wild-type, whereas SP4 subsets
exhibited relatively impaired signaling (Figure 4A). This result
demonstrates opposing effects of CD45 in distinct thymic
subsets and was evident in mixed bone marrow chimeras,
confirming that this signaling phenotype is cell intrinsic (Fig-
ure S4A). L/L DP thymocytes displayed hyperresponsive calcium
flux to TCR stimulation as well (Figure 4B). Importantly, PMA-
induced Erk-phosphorylation and ionomycin-induced calcium
flux were comparable across genotypes (Figures 4A and 4B).
To determine whether altered TCR surface expression on L/L
DP thymocytes accounted for our results, we reassessed Erk-
phosphorylation in the context of staining for surface TCRb
expression. By gating upon matched TCR surface expression
in WT and L/L thymocytes, we demonstrated that TCR hyperres-
ponsiveness in L/L DP thymocytes was independent of TCR
surface expression (Figures S4B and S4C).
TCR-induced Erk phosphorylation was assayed across a
range of CD45 expression in DP and SP4 thymocytes (Figure 4C).
In both thymic subsets, CD45 expression was absolutely
required for inducible TCR signaling (Stone et al., 1997). Low
expression of CD45 was sufficient to reconstitute signaling in
DP thymocytes, whereas higher expression of CD45 was
required to fully rescue signaling in SP4 thymocytes to wild-
type levels. TCR signaling in both subsets was dampened by
high CD45 expression, suggesting that CD45 plays a negative
regulatory role during inducible signaling.
To determine the qualitative effect of CD45 expression on the
dose response curve, we performed extensive dose titrations
across the allelic series (Figure S4D). By ‘‘flattening’’ (or reducing)
the slope of the dose response curve (Figure S4D), high CD45
expression might expand the ‘‘dynamic range’’ of antigenImmunity 32, 342–354, March 26, 2010 ª2010 Elsevier Inc. 347
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Figure 5. CD45 Differentially Controls Lck and Fyn Regulatory Tyro-
sine Phosphorylation
(A) Whole-cell lysates of resting allelic series thymocytes were blotted with Ab
to the inhibitory and activating tyrosines of Lck (Lck505/Src416). Src416 Ab
binds activating tyrosines of all SFKs; the lower band represents p56 Lck
and the upper band represents p59 Fyn. Total Lck is stained as a loading
control.
(B and C) Whole-cell lysates of purified DP (C) or SP4 (D) thymocytes from L/L
and WT mice were blotted with Ab as described in (A).
(D) Fyn IPs from whole-cell lysates of resting allelic series thymocytes were
blotted with Ab to the inhibitory and activating tyrosines of Fyn (Src 527/Src
416). Total Fyn was stained as a loading control. Blots in this figure are repre-
sentative of at least three independent experiments.
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checkpoint. This difference is likely to have important conse-
quences for thymic repertoire selection. Such marked decreased
responsiveness in the dose response studies for higher levels of
CD45 was not seen in the more mature SP4 population.
CD45 Differentially Affects Lck and Fyn Regulatory
Tyrosine Phosphorylation
To determine the biochemical mechanism by which CD45 dose
perturbs basal and inducible signaling, we assayed site-specific
phosphorylation of the SFKs in thymocytes. Unstimulated
whole-cell lysates were probed for phosphorylation at the acti-
vating (Y394) and inhibitory (Y505) tyrosines of Lck, the T cell-
specific SFK. With reduced CD45 expression, progressive
hyperphosphorylation at both sites was seen (Figure 5A). Dual
hyperphosphorylation of both tyrosines was observed in purified
L/L DP and SP thymic subsets (Figures 5B and 5C).348 Immunity 32, 342–354, March 26, 2010 ª2010 Elsevier Inc.The relative sensitivity of these two phosphorylation sites to
CD45 dose was different. Much higher CD45 expression was
required to dephosphorylate the activating tyrosine of Lck,
Y394, suggesting it is a poorer affinity substrate. Nevertheless,
we noted that even inhibitory Y505 required high CD45 expres-
sion for maximal dephosphorylation (Figure 5A).
To assess whether Fyn and Lck phosphorylation are differen-
tially regulated, we immunoprecipitated Fyn from thymic lysates
of the allelic series and probed it for phosphorylation at the acti-
vating and inhibitory tyrosines. High CD45 expression promotes
dephosphorylation of the activation loop tyrosine of Lck, but has
the opposite effect on the Fyn activation loop tyrosine (Figures
5A and 5D).Supraphysiologic CD45 Enhances Basal and Inhibits
Inducible TCR Signaling
‘‘HE’’ mice express supraphysiologic amounts of CD45 on
the surface of hematopoietic cells and were generated by ex-
pressing a properly splicing CD45 ‘‘H’’ transgene under the
control of the LFA-1 promoter in addition to endogenous ‘‘E’’
CD45 alleles (Virts et al., 2003). Two copies of the H transgene
locus superimposed on both copies of the wild-type CD45
produced a mouse (‘‘HE’’) in which thymocytes express
125% of normal CD45 on their surface.
We probed endogenous beta selection and positive selection
in HE mice by assessing the transition between DN3 and DN4
thymic subsets, and between pre- and postselection DP
subsets, respectively (Figures S5A and S5B). Supraphysiologic
‘‘HE’’ CD45-expressing mice fall on an extended continuum
with the allelic series and appear to have a dichotomous effect
on these processes relative to low CD45-expressing mice.
Whereas L/L and L/ thymi exhibit impaired beta selection,
but enhanced DP selection, ‘‘HE’’ thymi demonstrated enhanced
beta selection, with impaired DP selection.
Progressive dephosphorylation of both activating and inhibi-
tory tyrosines of Lck was detected in the presence of supraphy-
siologic CD45 expression, supporting both tyrosines as CD45
substrates (Figures S5C–S5E).
Consistent with positive selection, inducible TCR signaling
was inhibited in ‘‘HE’’ thymocytes in contrast to L/L thymocytes
(Figures S5F and S5G). This demonstrates the negative regula-
tory role of CD45 during inducible TCR signaling.
The addition of the high-expressing ‘‘HE’’ CD45 line to the
allelic series serves to establish that the biochemical, signaling,
and developmental consequences of perturbing CD45 dose
are independent of the lightning mutation and relate instead
purely to protein expression. Furthermore, physiologic wild-
type CD45 expression exists along a continuum of biochemical,
signaling, and developmental phenotypes, rather than at a peak
or trough.The Negative Regulatory Role of CD45 during Thymic
Development Is Independent of Fyn
The two SFKs expressed in T cells, Lck and Fyn, are partially
redundant but also have distinct physiological roles (Appleby
et al., 1992; Stein et al., 1992; Zamoyska et al., 2003). In order
to understand which of these two CD45 substrates mediate
the basal and inducible phenotypes of allelic series thymocytes,
Phospho-Erk Phospho-Erk
DP Thymocytes SP4 Thymocytes
Fyn+/+ Fyn-/- Fyn+/+ Fyn-/-
0μg αCD3ε
2μg αCD3ε
5μg αCD3ε
25μg αCD3ε
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A B
C D
E F
L/L
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Figure 6. Fyn Accounts for Differential Re-
gulation of Inducible TCR Signaling by CD45
in DP and SP4 Thymic Subsets
(A and B) Histograms depict intracellular phospho-
Erk in TCR-stimulated DP and SP subsets from
L/L (black line) or Ptprc+/+ (gray shaded histogram)
mice on either a Fyn+/+ or Fyn/ genetic back-
ground.
(C–F) Graphs represent quantification of data from
(A and B) along with the addition of L/+ Fyn+/+ and
L/+ Fyn/ mice. Data are representative of two
independent experiments.
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ground.
We analyzed thymic development, signaling, and SFK phos-
phorylation in Fyn-deficient allelic series thymi. Fyn deficiency
did not influence basal Lck phosphorylation in L/L or L/+ thymi
(Figure S6A). We assessed progression from DP to SP4 subset
and between preselection CD5loTCRbint and postselection
CD5hiTCRbhi DP subsets in Fyn-deficient L/L animals to evaluate
positive selection (Figures S6B and S6C). We found that Fyn
deficiency had no effect upon these phenotypes in allelic series
mice. Therefore, both the effect of CD45 upon Lck phosphoryla-
tion and the negative regulatory role of CD45 in inducible TCR
signaling are not mediated by Fyn.
We also assessed basal signaling in Fyn-deficient L/L thymo-
cytes by evaluating CD5 and TCRb expression on the surface
of preselection DP thymocytes. As described earlier, theseImmunity 32, 342–35markers were down and upregulated
respectively on L/L thymocytes as a result
of impaired basal signaling intensity. We
found that these phenotypes were also
completely unaffected by Fyn deficiency
(Figure S6C and data not shown). More-
over, basal z-phosphorylation, previously
demonstrated to depend upon Lck, was
normal in Fyn-deficient thymi (data not
shown). This is consistent with a CD45-
dependent, Fyn-independent basal
signaling pathway in DP thymocytes and
identifies a critical distinction between
the physiological roles of partially redun-
dant SFKs Fyn and Lck. Taken together,
these data suggest that Lck rather than
Fyn mediates the effect of CD45 expres-
sion upon these phenotypes. However,
this does not rule out a redundant role
for Fyn, which is masked by physiologic
Lck expression.
Differential Dependence upon Fyn
and Lck in TCR Signaling in DP
and SP Subsets
The expression patterns of Fyn and Lck
differ among T cell subsets. Specifically,
it has been reported that Fyn is signifi-cantly upregulated after the DP stage of thymic development
(Olszowy et al., 1995). Although Fyn lacks a nonredundant role
in DP thymocytes during basal or inducible TCR signaling
(Figure S6; Mamchak et al., 2008; Zamoyska et al., 2003), we
hypothesized that Fyn might contribute to signaling differences
between DP and SP4 thymocytes in allelic series mice
(Figure 4C).
To test this hypothesis, we assayed TCR signal transduction
in allelic series thymocytes deficient for Fyn. Although Fyn defi-
ciency minimally influenced signaling in DP thymocytes (Figures
6A, 6C, and 6E), loss of Fyn expression had a profound effect
upon TCR signaling in SP4 thymocytes from allelic series mice
(Figures 6B, 6D, and 6F). In the absence of Fyn, SP4 signaling
was significantly dampened in all allelic series mice, and differ-
ential regulation of DP and SP4 signaling by CD45 was no
longer evident (Figures 4C and 6). Thus, signaling through Fyn4, March 26, 2010 ª2010 Elsevier Inc. 349
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Figure 7. Csk Dose Reduction Uncouples
Basal and Inducible Signaling during Thymic
Development
(A) Representative histograms of TCRb expression
on preselection DP thymocytes from L/ and L/L
mice on either a Csk+/+ or Csk+/ genetic back-
ground (black line). Ptprc/ Csk+/+ sample (gray
shaded histogram) is plotted for reference.
(B) Quantification of data presented in (A) along
with the addition of L/+ Csk+/+ and L/+ Csk+/
mice. Values are the mean of at least three inde-
pendent experiments ± SEM, normalized to the
wild-type.
(C) Histograms depict intracellular phospho-Erk in
TCR-stimulated DP subsets from L/L or L/+ (black
line) or Ptprc+/+ (gray shaded histogram) mice on
either a Csk+/+ or Csk+/ genetic background.
(D) Quantification of data presented in (A) along
with the addition of Ptprc/, Csk+/, L/ Csk+/+,
and L/ Csk+/ mice. Values are the mean of at
least three independent experiments ± SEM.
p values listed on the graph are nonsignificant
and intended to demonstrate absence of rescue
by Csk dose reduction. Statistical analysis with
unpaired t tests was performed; *p < 0.05; **p <
0.005; ***p < 0.0005.
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and SP4 thymic subsets. Importantly, L/L Fyn/ DP and SP4
thymocytes were each hyperresponsive relative to Fyn/
thymocytes, suggesting that Lck rather than Fyn mediates the
negative regulatory role of CD45 during inducible TCR signaling
(Figures 4 and 6). This is consistent with a unique role for CD45
in dephosphorylating the activation loop tyrosine of Lck but not
Fyn (Figure 5).
Csk Uncouples CD45 Effect on Basal and Inducible
Signaling during Development
Csk and CD45 reciprocally regulate the inhibitory tyrosines of
the SFKs and are uniquely specialized to target this substrate.
Csk activity is, in turn, regulated by its dynamic localization.
Csk is constitutively recruited to lipid rafts, in part, by the adaptor
PAG. Upon receptor stimulation, PAG is rapidly dephosphory-
lated and Csk is released to the cytoplasm (Brdicka et al.,
2000; Kawabuchi et al., 2000). Because Csk is dynamically relo-
calized upon TCR stimulation, we reasoned that reducing Csk
dosage (Csk+/) in allelic series mice ought to affect basal but
not inducible signaling. Furthermore, we examined whether
the negative regulatory role of CD45 was an indirect result of
dephosphorylating the inhibitory tyrosine of Lck or rather an
independent and direct effect mediated by dephosphorylation
of the activation loop tyrosine of Lck. We hypothesized that if
the latter were true, reducing Csk dosage and thus phosphoryla-
tion of the inhibitory tyrosine of Lck ought not to affect inducible
signaling by allelic series DP thymocytes.
To test these hypotheses, we generated Csk+/ allelic series
animals. We assessed basal signaling by assaying expression
of TCRb and CD5 in preselection DP thymocytes. We observed
rescue of these basal signaling phenotypes in allelic series350 Immunity 32, 342–354, March 26, 2010 ª2010 Elsevier Inc.animals with Csk dose reduction (Figures 7A and 7B and Figures
S7A and S7B). Interestingly, the rescue produced by halving Csk
dose precisely corresponded to a doubling of CD45 expression
such that, for instance, Csk+/ L/ thymocytes resembled L/L
thymocytes. We assessed beta selection in these mice and
saw similar rescue of this ligand-independent signaling check-
point (Figures S7C and S7D).
We next assessed inducible TCR signaling in allelic series DP
thymocytes and observed no effect or rescue with reduced Csk
dosage (Figures 7C and 7D). Interestingly, we also observed that
reduced thymic cellularity in L/L and L/ mice was not rescued
by Csk dose reduction (Figure S7E). This implies that reduced
cellularity is not due to impaired beta selection given that the
latter process is rescued by Csk haploinsufficiency.
Taken together, these data suggest that Csk regulates basal
but not inducible signaling in DP thymocytes. This in turn
implies that basal signaling is regulated by CD45 exclusively
through its effects on the inhibitory tyrosine of the SFKs. In
contrast, the negative regulatory role of CD45 during inducible
TCR signaling in DP thymocytes is independent of the inhibitory
tyrosine, suggesting that the direct dephosphorylation of the
activation loop tyrosine of Lck by CD45 mediates this effect.
Simple haploinsufficiency of Csk in the context of the allelic
series uncouples the contribution of inhibitory and activation
loop tyrosines of Lck to basal and inducible signaling, respec-
tively (Figure S7F).
DISCUSSION
We have described a CD45 allele, lightning, characterized by
a mutation in the protein’s extracellular domain. CD45 protein
expression was reduced because of impaired protein stability
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splicing was unperturbed and the polymorphism is structurally
insulated from the cytoplasmic phosphatase domain.
CD45 isoform expression is tightly regulated and may affect
protein function through differential dimerization or differential
association with the CD4 coreceptor (Dornan et al., 2002; Xu
and Weiss, 2002). In contrast to previously published series of
CD45 transgenic lines in which single isoforms of CD45 are
expressed at a range of doses (McNeill et al., 2007; Salmond
et al., 2008), the lightning allelic series titrates protein expression
while preserving isoform splicing. By including both Ptprc+/
animals and the high-expressing CD45 ‘‘HE’’ line in our studies,
we conclude that the phenotypes we identified were not due to
an idiosyncratic effect of the lightning mutation.
We have demonstrated distinct requirements for CD45 in
basal and inducible TCR signaling during thymic development
that are obscured in the context of complete CD45 deficiency.
Whereas Ptprc/ mice have previously revealed an absolute
requirement for CD45 in positive selection, and a partial require-
ment during beta selection (Byth et al., 1996; Kishihara et al.,
1993; Mee et al., 1999), the lightning allelic series has uncoupled
these processes, revealing that low CD45 doses are sufficient to
rescue the former, but high doses are required to correct the
latter. Additional indicators of impaired basal signaling in
Ptprc/ thymocytes (CD5 expression, constitutive z-chain
phosphorylation, and TCR surface expression) were rescued
only with high CD45 expression. In contrast, biochemical indica-
tors of inducible TCR signal intensity in DP thymocytes showed
rescue of CD45-dependent defects even at very low CD45
expression.
Inducible signaling via MHC presentation of antigen recruits
coreceptor-associated Lck to the TCR. In contrast, neither
beta selection nor basal or weak nonselecting MHC signals
effectively recruit or require coreceptor. Indeed, although consti-
tutive z-chain phosphorylation in DP thymocytes has been
demonstrated to depend upon nonselecting MHC and Lck, it is
coreceptor independent (Becker et al., 2007; van Oers et al.,
1996a; van Oers et al., 1993). We propose therefore that inde-
pendent pools of CD4-associated and ‘‘free’’ Lck may be differ-
entially regulated by CD45 and independently mediate basal and
inducible signaling (Falahati and Leitenberg, 2007; Leitenberg
et al., 1996).
The distinct requirements for CD45 expression during basal
and inducible signaling might also relate to the dynamic localiza-
tion of Csk (Brdicka et al., 2000; Kawabuchi et al., 2000). High
amounts of Csk bound to PAG and localized to Lck in lipid rafts
in the basal state might require high expression of CD45 to
counteract Lck Y505 phosphorylation, whereas loss of Csk
from lipid rafts upon TCR stimulation might explain why even
low doses of CD45 are sufficient to mediate inducible TCR sig-
naling. Indeed, consistent with this model we have demon-
strated that reduced Csk dosage rescued basal but not inducible
signaling phenotypes in L/ and L/L DP thymocytes.
CD45 is expressed at extremely high amounts on the surface
of hematopoietic cells, by some estimates up to 25 mM (data
not shown). Yet, the reason for this apparent overabundance
remains uncertain, especially when no definitive physiologically
relevant ligand has been identified in 20 years of searching. We
propose that one reason why so much CD45 is required on thesurface of cells may be to counteract membrane-associated
Csk in the basal state.
Although very low doses of CD45 are sufficient to rescue
inducible TCR signaling and positive selection, high amounts
of CD45 dampen these processes. The allelic series has
unmasked a negative regulatory role for CD45 that is obscured
in Ptprc/ animals by its positive regulatory role.
CD45 has been postulated to negatively regulate TCR
signaling by dephosphorylating the activating Lck tyrosine 394
(McNeill et al., 2007). Dual hyperphosphorylation of Lck at both
inhibitory and activating tyrosines has been reported in many
CD45-deficient cell lines and mice (Ashwell and D’Oro, 1999).
Here we also have identified dual hyperphosphorylation of
Lck at tyrosines 394 and 505 with decreasing doses of CD45.
Importantly, we observed progressive dephosphorylation at
these sites with supraphysiologic expression of CD45, suggest-
ing that any dimerization that occurs at high surface density is
insufficient to completely inhibit phosphatase activity. Maximal
Y394 phosphorylation at low CD45 expression levels correlates
with maximal inducible TCR signaling in DP thymocytes.
We suggest that in the presence of even low amounts of
CD45, Y394 rather than Y505 phosphorylation ‘‘dominantly’’
controls the sensitivity of inducible TCR signaling.
Reducing Csk dosage rescued basal signaling in allelic series
thymocytes and implies that CD45 is required to counteract Csk
phosphorylation of Lck Y505 in the basal state. Lck Y505 phos-
phorylation dominantly controls Lck activity under these condi-
tions. By contrast, reduced Csk dosage did not affect inducible
signaling in DP thymocytes, implying that phosphorylation of Lck
Y505 does not mediate inducible signaling phenotypes of allelic
series mice. Given that high CD45 expression dampens induc-
ible TCR signaling, we conclude that CD45 negatively regulates
Lck activity through an alternate substrate, most likely the activa-
tion loop tyrosine Y394. Our data support a model whereby Lck
Y394 is directly dephosphorylated by CD45, independently of
Csk and its unique substrate Lck Y505.
Although dual activating and inhibitory tyrosine phosphoryla-
tion of Lck has been observed in CD45-deficient T cells and
T cell lines, other CD45-deficient hematopoietic cells, including
B cells and macrophages, do not exhibit hyperphosphorylation
of SFK activation loop tyrosines (Zhu et al., 2008). This is more
consistent with the regulation of Fyn activating tyrosine phos-
phorylation in our allelic series thymocytes and suggests that
Lck regulation by CD45 is unique among the SFKs. This may
be the result of differential localization of the SFKs because
Lck is uniquely associated with CD4 coreceptor and, conse-
quently, with CD45 (Veillette et al., 1988). The activating tyrosine
of Lck may only function as an important CD45 substrate at high
CD45 doses and in close proximity such that Lck is uniquely
regulated by CD45 with respect to other SFKs.
We have identified differential regulation of inducible sig-
naling in DP and SP subsets by CD45 and have demonstrated
that Fyn rather than Lck accounts for these differences. Impor-
tantly, Fyn does not play a nonredundant role in either basal
signaling or negative regulation of inducible signaling by
CD45. Unpublished data from our lab suggests that the CD45
requirement for signaling by peripheral T cells is similar to
that in SP4 rather than DP thymocytes, implying that DP thymo-
cytes are unique among T cells. Indeed, prior studies hadImmunity 32, 342–354, March 26, 2010 ª2010 Elsevier Inc. 351
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Roles of CD45 and Csk during Thymic Developmentsuggested that very low levels of CD45 expression were suffi-
cient to reconstitute thymic development, while much higher
levels were required to rescue TCR signaling in peripheral
T cells (Kozieradzki et al., 1997; McNeill et al., 2007; Ogilvy
et al., 2003). We propose that this discrepancy is actually due
to the distinct CD45 requirements of DP thymocytes and
mature T cells which are in turn the result of differential roles
of Fyn and Lck in these subsets.
This differential cell-type specific TCR ‘‘wiring’’ has interesting
implications for DP thymocyte signaling. Perhaps low Fyn
expression forces DP thymocytes to be more dependent upon
coreceptor-associated Lck. This would further enforce MHC-
dependence during thymic positive selection (Van Laethem
et al., 2007). Also, such coreceptor associated Lck is itself
more tightly regulated by CD45 than ‘‘free’’ Lck (Falahati and Lei-
tenberg, 2007). By dialing down activating Y394 phosphorylation
of Lck at physiologic doses of CD45, the dynamic range of
antigen recognition by DP thymocytes is enhanced at a crucial
developmental checkpoint.
The lightning allelic series demonstrates that hypomorphic
alleles of known genes can unmask previously obscured func-
tions. Indeed, the physiologic relevance of CD45 dose is high-
lighted by recent studies demonstrating that mice expressing
intermediate CD45 are resistant to fatal Ebola and Anthrax infec-
tions to which both wild-type and CD45/ mice succumb (Pan-
chal et al., 2009a; Panchal et al., 2009b).
We conclude by suggesting that high physiologic expression
of CD45 on the surface of T cells serves two functions: first, to
counteract Csk activity during basal signaling and, second, to
negatively regulate TCR signaling specifically in DP thymocytes,
thereby expanding the dynamic range of ligand-receptor interac-
tions at a critical developmental checkpoint. This provides
a unique solution to the central problem of the adaptive immune
system: how, in the face of a universe of unknown antigens, to
generate working receptors that respond sensitively, but not
too sensitively.
EXPERIMENTAL PROCEDURES
Mice
Lightning mice were generated directly on the C57BL/6 genetic background
during N-ethyl-N-nitrosourea mutagenesis screen conducted at Australian
National University and backcrossed at least six generation. Mutagenesis
and mapping were performed as previously described (Nelms and Goodnow,
2001). HE, Ptprc/, Csk/, Fyn/ mice, and OTII TCR transgenic mice
were previously described (Barnden et al., 1998; Imamoto and Soriano,
1993; Kishihara et al., 1993; Stein et al., 1992; Virts et al., 2003). All mutant
strains were fully backcrossed to a C57BL/6 genetic background. Mice were
used at 5–9 weeks of age for all experiments. All mice were housed in a specific
pathogen-free facility at UCSF according to the University Animal Care
Committee and National Institutes of Health (NIH) guidelines.
Bone Marrow Chimeras
Host mice (CD45.1 or CD45.1/CD45.2 heterozygotes) were lethally irradiated,
reconstituted with lightning and/or wild-type bone marrow (CD45.1 or
CD45.2), and analyzed at 6–10 weeks postirradiation. Further experiments
were performed as described below.
Antibodies and Reagents
Murine CD3, CD4, CD5, CD8, CD25, CD44, panCD45, CD45RA, RB, RC,
B220, CD45.1, CD45.2, CD69, CD19, gd, NK1.1, pNK, CD11b, CD11c, Gr,
TCRb, Va2, and Vb5 Ab conjugated to FITC, PE-Texas Red, PE, PerCP-352 Immunity 32, 342–354, March 26, 2010 ª2010 Elsevier Inc.Cy5.5, PE-Cy5.5, PE-Cy7, Pacific Blue, APC, or Alexa 647 (eBiosciences or
BD Biosciences) were used for FACS staining. Nur77 Ab (BD) and phospho-
Erk (197G2) (Cell Signaling) Ab were used for intracellular staining. Lck 505
(BD), Scr 416, Src 527, and Fyn Ab (Cell Signaling) were used for westerns
as were phospho-tyrosine (4G10), Lck (1F6), and z (6B10) Ab prepared in
our laboratory. Fyn Ab (Santa Cruz) was used for IP. Unconjugated CD33
(2C11) Ab (Harlan) and goat anti-armenian hamster IgG(H+L) Ab were used
for TCR stimulation. Goat anti-rabbit /IgG-APC (Jackson Immunoresearch)
and anti-Donkey Alexa 488 (Molecular Probes) Ab were used for secondary
intracellular staining.
Real-Time PCR and Sequencing
cDNA was prepared with Trizol reagent protocol and random hexamer priming
with SuperscriptIII kit (Invitrogen). Real-time PCR was performed with CD45
and GAPDH Taqman primers (ABI). PCR products were amplified from
cDNA with a series of nested primers (Operon) traversing the CD45 transcript
and then sequenced (ELIM). Lightning mutation numbering (F503) is derived
from the convention that the juxtamembrane wedge glutamate is E613 in
mouse (Majeti et al., 2000).
Flow Cytometry and Data Analysis
Cells were stained with indicated Ab and analyzed on FACSCalibur (Becton
Dickson) or CyAN ADP (DAKO) as previously described (Hermiston et al.,
2005). Data analysis was performed with FlowJo (v8.8.4) software (Treestar
Incorporated). Statistical analysis with unpaired t tests was performed with
Prism v4c (GraphPad Software). Structural modeling was performed with
PyMOL version 1.1beta2 software (DeLano Scientific).
Intracellular Staining for CD45 or TCRb
Single-cell suspensions were surface-stained, fixed (BD cytofix), stained for
intracellular CD45 or TCRb with fluorophore-conjugated Ab in saponin-based
medium B (Caltag), and washed with Perm/Wash (BD Biosciences).
CD45 Turnover Studies
Single-cell suspensions of thymocytes were incubated at 37C in complete
media with 100 mg/ml cycloheximide (CHX; Sigma). At indicated time points,
cells were stained for intracellular CD45 as described above.
Intracellular Staining for Nur77
Thymocytes were stimulated with plate-bound CD33 with or without CD28
mAbs for 2 hr in 10% RPMI at 37C. Cells were then fixed, permeabilized
with MeOH, washed, and stained first with Nur77 Ab and then with secondary
anti-Donkey Alexa 488 Ab along with staining for surface markers.
Thymocyte Stimulation, Calcium Flux, and Intracellular
Phospho-Erk Staining
These assays were performed as previously described (Zikherman et al.,
2009). Surface staining of fixed, stimulated thymocytes with TCRb-FITC anti-
body prior to permeabilization allowed simultaneous assessment of phospho-
Erk and TCR expression.
Immunoprecipitation and Immunoblotting
Immunoprecipitation and immunoblotting were performed as previously
described (Zhu et al., 2008). Purified cell populations of SP4 and DP thymo-
cytes were obtained by sorting.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and can be found with this
article online at doi:10.1016/j.immuni.2010.03.006.
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